Press Releases

Press Release

Cardiol Therapeutics Receives FDA Approval for Investigational New Drug (IND) Application for Phase II/III COVID-19 Trial

September 25, 2020

Press Release

Cardiol Therapeutics to Present at the H.C. Wainwright Virtual 22nd Annual Global Investment Conference

September 15, 2020

Press Release

Cardiol Therapeutics Initiates Health Canada Approved Phase 1 Clinical Study of CardiolRx™

August 26, 2020

Press Release

Cardiol Therapeutics Appoints CNBC Market Analyst Steven Grasso as Business Advisor

June 29, 2020

Press Release

David Elsley Files Early Warning Report for Cardiol Therapeutics

June 25, 2020

Press Release

Cardiol Therapeutics Closes $17.25 Million Bought Deal Offering, Including Full Exercise of the Over-Allotment Option

June 04, 2020

Press Release

Cardiol Therapeutics Reports 2020 AGM Results

June 02, 2020

Press Release

Cardiol Therapeutics to Webcast Virtual Annual General Meeting on June 1st at 4:30 p.m. EDT

May 29, 2020

Press Release

Cardiol Therapeutics Announces Increase to Previously Announced Bought Deal Public Offering

May 14, 2020